EFMC Best Poster Prizes

The EFMC Best Poster Prizes have been granted to the following participants :

• P096 - Yasuhiro Imaeda (Takeda Pharmaceutical Company, Japan)
  DISCOVERY OF TAK-272: A NOVEL, POTENT AND ORALLY ACTIVE RENIN INHIBITOR
  
  
• P036 - Dmitrii Kalinin (University of Münster, Germany)
  DESIGN, SYNTHESIS AND ANTIBACTERIAL ACTIVITY OF PROLINE HYDROXAMATES TARGETING ZINC-DEPENDENT ENZYMES
  
  
• P132 - Nis Halland (Sanofi, Germany)
  NOVEL SMALL MOLECULE INHIBITORS OF ACTIVATED THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFIa) FROM NATURAL PRODUCT ANABAENOPEPTIN
  
  
• P192 - Geoffrey Schwertz (ETH Zurich, Switzerland)
  SHMT INHIBITION: A NEW HOPE TO DEFEAT MALARIA
  
  
• P253 - Xavier Lucas (University of Dundee, United Kingdom)
  PROTACTING LEADS: DESIGN OF A PROTEIN SURFACE-TARGETING FRAGMENT LIBRARY
  
  
• P334 - Jonas Kaindl (Friedrich-Alexander-University Erlangen-Nuernberg, Germany)
  STRUCTURE-GUIDED DEVELOPMENT AND MOLECULAR MODELLING OF D2R/NTS1R HETERODIMER-SELECTIVE LIGANDS
  
  
• P444 - Arno Vermote (Ghent University, Belgium)
  POTENTIATOR DRUGS FOR BAD BUGS - HAMAMELITANNIN ANALOGUES POTENTIATE ANTIBIOTICS IN THE FIGHT AGAINST STAPHYLOCOCCUS AUREUS
  
  
• P466 - Liam Hudson (Institute of Cancer Research, United Kingdom)
  DEVELOPMENT OF A NEW CLASS OF ALK2 INHIBITOR FOR THE STUDY OF THE MOST AGGRESSIVE PAEDIATRIC BRAIN CANCER, DIPG
  
  
• P592 - Christian Kersten (Johannes Gutenberg University, Germany)
  SELECTIVITY DETERMINING FEATURES IN N-MYRISTOYLTRANSFERASES - A POTENTIAL DRUG TARGET WITH A HIGHLY CONSERVED BINDING SITE
  
  
• P522 - Daniela Dengler (Friedrich-Alexander University Erlangen-Nuremberg, Germany)
  DISCOVERY OF A G-PROTEIN BIASED MU OPIOID ANALGESIC WITH REDUCED SIDE EFFECTS